Follow
Xavier Mariette
Xavier Mariette
Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, INSERM
Verified email at aphp.fr
Title
Cited by
Cited by
Year
World malaria report 2022
World Health Organization
World Health Organization, 2022
13807*2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ...
Annals of the rheumatic diseases 76 (6), 960-977, 2017
80112017
Classification criteria for Sjögren’s syndrome
C Vitali, N Del Papa
Sjögren's Syndrome, 47-60, 2016
63472016
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ...
Arthritis & rheumatology 71 (9), 1400-1412, 2019
25712019
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ...
Nature 506 (7488), 376-381, 2014
24112014
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data‐driven methodology …
CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ...
Arthritis & rheumatology 69 (1), 35-45, 2017
22982017
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
O Hermine, F Lefrère, JP Bronowicki, X Mariette, K Jondeau, ...
New England Journal of Medicine 347 (2), 89-94, 2002
9792002
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome
R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ...
Annals of the rheumatic diseases 69 (6), 1103-1109, 2010
9662010
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial
O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ...
JAMA internal medicine 181 (1), 32-40, 2021
8782021
Immune-related adverse events of checkpoint inhibitors
M Ramos-Casals, JR Brahmer, MK Callahan, A Flores-Chávez, N Keegan, ...
Nature reviews Disease primers 6 (1), 38, 2020
8222020
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...
Annals of the rheumatic diseases 73 (6), 958-967, 2014
7872014
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three‐year prospective …
F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
7752009
Primary Sjögren’s syndrome
X Mariette, LA Criswell
New England Journal of Medicine 378 (10), 931-939, 2018
7572018
Sjögren syndrome
P Brito-Zerón, C Baldini, H Bootsma, SJ Bowman, R Jonsson, X Mariette, ...
Nature reviews Disease primers 2 (1), 1-20, 2016
7212016
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome
X Mariette, S Roux, J Zhang, D Bengoufa, F Lavie, T Zhou, R Kimberly
Annals of the rheumatic diseases 62 (2), 168-171, 2003
7162003
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized …
JP Fermand, P Ravaud, S Chevret, M Divine, V Leblond, C Belanger, ...
Blood, The Journal of the American Society of Hematology 92 (9), 3131-3136, 1998
7081998
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome
JE Gottenberg, N Cagnard, C Lucchesi, F Letourneur, S Mistou, T Lazure, ...
Proceedings of the National Academy of Sciences 103 (8), 2770-2775, 2006
6982006
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates
K Fizazi, A Lipton, X Mariette, JJ Body, Y Rahim, JR Gralow, G Gao, L Wu, ...
Journal of Clinical Oncology 27 (10), 1564-1571, 2009
6372009
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome
CJ Lessard, H Li, I Adrianto, JA Ice, A Rasmussen, KM Grundahl, JA Kelly, ...
Nature genetics 45 (11), 1284-1292, 2013
5532013
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)
X Mariette, P Ravaud, S Steinfeld, G Baron, J Goetz, E Hachulla, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2004
5472004
The system can't perform the operation now. Try again later.
Articles 1–20